Changing tomorrow

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients.

An executive reviews interactive financial data as part of Astellas’ Q3 FY2024 performance reporting.

Financial results for Q1 YTD/FY2025

Astellas announced our financial results for Q1 YTD/FY2025 on July 30th. The Presentation material, video, and meeting script are now available.

Our stories

Shaping tomorrow
  • Innovation

Shaping tomorrow, together: How partnerships can unlock scientific innovation for patients

Science, collaboration and breakthroughs
  • Innovation
  • Patient focus

Science, collaboration and breakthroughs: Insights from Astellas' Life Sciences and West Coast Innovation Centers

Eye diseases
  • Innovation
  • Patient focus

Every day of vision loss is one too many: Addressing the impact of eye diseases

Exterior view of Astellas’ Tokyo headquarters, home to a global life sciences company shaping healthcare worldwide.

About Astellas

Astellas is headquartered in Tokyo, Japan and operates in more than 70 countries and areas around the world.

Hands held in a quiet moment of care, echoing Astellas’ focus on improving lives through patient-centered innovation.

Medicines and Disease Areas

Astellas provides transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. 

Molecular models used in Astellas’ research and development to advance innovative therapies in high- need disease areas.

Research and Development

Through our research and development (R&D) programs, we are pioneering new healthcare solutions in disease areas with high unmet medical need.

Astellas scientists work together at a whiteboard as part of a culture that values bold ideas and collaborative innovation.

Careers

Astellas brings together experts from around the world and some of the brightest talent in the industry – all united in our dedication to pursuing brave ideas and ambitious outcomes.